I was diagnosed with remitting relapsing MS in Dec 2019. 12 lesions but “only” sensory temperature and numbness symptoms in my left leg and left hand. I was lined up for another MRI and lumber puncture 3 months later. The lumber puncture results showed no signs of MS inflammatory markers, the MRI showed a new lesion and an active old one. I had MS. I was consulted about what treatment to start on and was offered Tecfidera or Ocrevus. I asked the neurologist what one he would start if he was me and he said Ocrevus as studies seem to show it’s better to hit MS hard early on for better long term outcomes. I agreed and I was in the waiting list and then Covid-19 changed the world. I was subsequently told no one was to start on Ocrevus because it would put me at higher risk with the world as it is now. So to my disappointment I then had to start Tecfidera instead. I’m grateful to have anything but I’ve read of more positive results from Ocrevus. There may be an opportunity in the future to switch from Tecfidera when things go back to “normal”. My question is has anyone else made the switch from Tecfidera to Ocrevus and seen much better disease delay?
Browse categories and add by clicking on them
You can remove current categories below by clicking the ‘x’.